Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IQV – IQVIA Holdings Inc.

IQVIA Holdings, Inc.
IQV
$157.47
Name : IQVIA Holdings, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $27,242,309,632.00
EPSttm : 7.32
finviz dynamic chart for IQV
IQVIA Holdings, Inc.
$157.47
0.44%
$0.69

Float Short %

5.44

Margin Of Safety %

7

Put/Call OI Ratio

1.47

EPS Next Q Diff

0.35

EPS Last/This Y

4.26

EPS This/Next Y

1.13

Price

157.48

Target Price

184.58

Analyst Recom

1.54

Performance Q

-12.2

Relative Volume

0.94

Beta

1.3

Ticker: IQV




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02IQV139.090.960.0579054
2025-06-03IQV142.770.951.0679412
2025-06-04IQV147.860.960.2879283
2025-06-05IQV147.320.960.1979321
2025-06-06IQV152.260.960.3279363
2025-06-09IQV154.140.962.6679445
2025-06-10IQV159.780.980.6280912
2025-06-11IQV158.840.970.4082125
2025-06-12IQV159.090.970.8982230
2025-06-13IQV156.880.980.3582271
2025-06-16IQV159.260.970.3182443
2025-06-17IQV154.10.971.4182508
2025-06-18IQV154.550.985.6683005
2025-06-20IQV154.781.023.9485482
2025-06-23IQV155.191.081.0181271
2025-06-24IQV158.641.500.1717650
2025-06-25IQV158.81.422.6218163
2025-06-26IQV158.121.424.0018202
2025-06-27IQV157.371.470.9918899
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02IQV139.095.1208.711.84
2025-06-03IQV142.785.1267.711.84
2025-06-04IQV147.855.1283.311.84
2025-06-05IQV147.375.1217.411.84
2025-06-06IQV152.295.0280.411.84
2025-06-09IQV154.155.0244.211.84
2025-06-10IQV159.795.0286.711.84
2025-06-11IQV158.855.0213.511.84
2025-06-12IQV159.135.0226.811.84
2025-06-13IQV156.875.0198.811.84
2025-06-16IQV159.295.0250.111.84
2025-06-17IQV154.095.0167.011.84
2025-06-18IQV154.615.0229.311.84
2025-06-20IQV154.735.0224.911.83
2025-06-23IQV155.225.0229.111.83
2025-06-24IQV158.595.0261.711.83
2025-06-25IQV158.77- 225.70.00
2025-06-26IQV158.15- 216.70.00
2025-06-27IQV157.484.9216.111.83
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02IQV0.08-1.003.25
2025-06-03IQV0.08-1.003.25
2025-06-04IQV0.08-1.003.25
2025-06-05IQV0.08-1.003.25
2025-06-06IQV0.08-1.003.25
2025-06-09IQV0.08-1.013.25
2025-06-10IQV0.08-1.013.25
2025-06-11IQV0.08-1.014.20
2025-06-12IQV0.08-1.014.20
2025-06-13IQV0.08-1.014.20
2025-06-16IQV0.08-2.644.20
2025-06-17IQV0.08-2.644.20
2025-06-18IQV0.08-2.644.20
2025-06-20IQV0.08-2.644.20
2025-06-23IQV0.08-3.614.20
2025-06-24IQV0.08-3.614.20
2025-06-25IQV0.08-3.614.20
2025-06-26IQV0.08-3.615.44
2025-06-27IQV0.08-3.615.44
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

2.7

Avg. EPS Est. Current Quarter

2.77

Avg. EPS Est. Next Quarter

3.05

Insider Transactions

0.08

Institutional Transactions

-3.61

Beta

1.3

Average Sales Estimate Current Quarter

3962

Average Sales Estimate Next Quarter

4072

Fair Value

168.7

Quality Score

72

Growth Score

74

Sentiment Score

57

Actual DrawDown %

44.9

Max Drawdown 5-Year %

-51.5

Target Price

184.58

P/E

21.46

Forward P/E

12.15

PEG

2.46

P/S

1.76

P/B

4.59

P/Free Cash Flow

12.59

EPS

7.34

Average EPS Est. Cur. Y​

11.83

EPS Next Y. (Est.)

12.96

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

8.61

Relative Volume

0.94

Return on Equity vs Sector %

-1.6

Return on Equity vs Industry %

11.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

216.1
IQVIA Holdings, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 89000
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
stock quote shares IQV – IQVIA Holdings Inc. Stock Price stock today
news today IQV – IQVIA Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IQV – IQVIA Holdings Inc. yahoo finance google finance
stock history IQV – IQVIA Holdings Inc. invest stock market
stock prices IQV premarket after hours
ticker IQV fair value insiders trading